Contribute Try STAT+ Today

A new federal research grant will enable the Framingham Heart Study, the nation’s longest-running multigenerational study of cardiovascular disease, to explore the biology of aging.

In the next phase of the 71-year-old study, researchers from Boston University’s School of Medicine will measure changes in traits such as blood pressure, stiffness of arteries, stickiness of blood platelets, and fat accumulation in the liver of participants — most of them children or grandchildren of Framingham residents first enrolled in the study in 1948.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.